These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

287 related articles for article (PubMed ID: 12509456)

  • 1. Extracellular matrix enhances heregulin-dependent BRCA1 phosphorylation and suppresses BRCA1 expression through its C terminus.
    Miralem T; Avraham HK
    Mol Cell Biol; 2003 Jan; 23(2):579-93. PubMed ID: 12509456
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Heregulin induces transcriptional activation of the progesterone receptor by a mechanism that requires functional ErbB-2 and mitogen-activated protein kinase activation in breast cancer cells.
    Labriola L; Salatino M; Proietti CJ; Pecci A; Coso OA; Kornblihtt AR; Charreau EH; Elizalde PV
    Mol Cell Biol; 2003 Feb; 23(3):1095-111. PubMed ID: 12529413
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of the MAP kinase cascade blocks heregulin-induced cell cycle progression in T-47D human breast cancer cells.
    Fiddes RJ; Janes PW; Sivertsen SP; Sutherland RL; Musgrove EA; Daly RJ
    Oncogene; 1998 May; 16(21):2803-13. PubMed ID: 9652748
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Heregulin induces phosphorylation of BRCA1 through phosphatidylinositol 3-Kinase/AKT in breast cancer cells.
    Altiok S; Batt D; Altiok N; Papautsky A; Downward J; Roberts TM; Avraham H
    J Biol Chem; 1999 Nov; 274(45):32274-8. PubMed ID: 10542266
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phosphatidylinositol 3-kinase/Akt signaling enhances nuclear localization and transcriptional activity of BRCA1.
    Hinton CV; Fitzgerald LD; Thompson ME
    Exp Cell Res; 2007 May; 313(9):1735-44. PubMed ID: 17428466
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Csk homologous kinase associates with RAFTK/Pyk2 in breast cancer cells and negatively regulates its activation and breast cancer cell migration.
    McShan GD; Zagozdzon R; Park SY; Zrihan-Licht S; Fu Y; Avraham S; Avraham H
    Int J Oncol; 2002 Jul; 21(1):197-205. PubMed ID: 12063569
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Heregulin beta1-activated phosphatidylinositol 3-kinase enhances aggregation of MCF-7 breast cancer cells independent of extracellular signal-regulated kinase.
    Tan M; Grijalva R; Yu D
    Cancer Res; 1999 Apr; 59(7):1620-5. PubMed ID: 10197638
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tiam1 overexpression potentiates heregulin-induced lymphoid enhancer factor-1/beta -catenin nuclear signaling in breast cancer cells by modulating the intercellular stability.
    Adam L; Vadlamudi RK; McCrea P; Kumar R
    J Biol Chem; 2001 Jul; 276(30):28443-50. PubMed ID: 11328805
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phosphatidylinositol 3-kinase recruitment by p185erbB-2 and erbB-3 is potently induced by neu differentiation factor/heregulin during mitogenesis and is constitutively elevated in growth factor-independent breast carcinoma cells with c-erbB-2 gene amplification.
    Ram TG; Ethier SP
    Cell Growth Differ; 1996 May; 7(5):551-61. PubMed ID: 8732665
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Heregulin inhibits proliferation via ERKs and phosphatidyl-inositol 3-kinase activation but regulates urokinase plasminogen activator independently of these pathways in metastatic mammary tumor cells.
    Puricelli L; Proietti CJ; Labriola L; Salatino M; Balañá ME; Aguirre Ghiso J; Lupu R; Pignataro OP; Charreau EH; Bal de Kier Joffé E; Elizalde PV
    Int J Cancer; 2002 Aug; 100(6):642-53. PubMed ID: 12209601
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tea polyphenol (-)-epigallocatechin 3-gallate suppresses heregulin-beta1-induced fatty acid synthase expression in human breast cancer cells by inhibiting phosphatidylinositol 3-kinase/Akt and mitogen-activated protein kinase cascade signaling.
    Pan MH; Lin CC; Lin JK; Chen WJ
    J Agric Food Chem; 2007 Jun; 55(13):5030-7. PubMed ID: 17539658
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Functional analysis of Csk and CHK kinases in breast cancer cells.
    Bougeret C; Jiang S; Keydar I; Avraham H
    J Biol Chem; 2001 Sep; 276(36):33711-20. PubMed ID: 11445575
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The extracellular region of heregulin is sufficient to promote mammary gland proliferation and tumorigenesis but not apoptosis.
    Weinstein EJ; Leder P
    Cancer Res; 2000 Jul; 60(14):3856-61. PubMed ID: 10919660
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prolactin and heregulin override DNA damage-induced growth arrest and promote phosphatidylinositol-3 kinase-dependent proliferation in breast cancer cells.
    Chakravarti P; Henry MK; Quelle FW
    Int J Oncol; 2005 Feb; 26(2):509-14. PubMed ID: 15645137
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Signaling molecules implicated in heregulin induction of growth arrest and apoptosis.
    Guerra-Vladusic FK; Vladusic EA; Tsai MS; Lupu R
    Oncol Rep; 2001; 8(6):1203-14. PubMed ID: 11605034
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Essential role for Rac in heregulin beta1 mitogenic signaling: a mechanism that involves epidermal growth factor receptor and is independent of ErbB4.
    Yang C; Liu Y; Lemmon MA; Kazanietz MG
    Mol Cell Biol; 2006 Feb; 26(3):831-42. PubMed ID: 16428439
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A functional comparison between the HER2(high)/HER3 and the HER2(low)/HER3 dimers on heregulin-β1-induced MMP-1 and MMP-9 expression in breast cancer cells.
    Kim S; Han J; Shin I; Kil WH; Lee JE; Nam SJ
    Exp Mol Med; 2012 Aug; 44(8):473-82. PubMed ID: 22627808
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Involvement of heregulin-beta2 in the acquisition of the hormone-independent phenotype of breast cancer cells.
    Tang CK; Perez C; Grunt T; Waibel C; Cho C; Lupu R
    Cancer Res; 1996 Jul; 56(14):3350-8. PubMed ID: 8764133
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Heregulin-beta1 regulates the estrogen receptor-alpha gene expression and activity via the ErbB2/PI 3-K/Akt pathway.
    Stoica GE; Franke TF; Wellstein A; Morgan E; Czubayko F; List HJ; Reiter R; Martin MB; Stoica A
    Oncogene; 2003 Apr; 22(14):2073-87. PubMed ID: 12687010
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Heregulin regulates cytoskeletal reorganization and cell migration through the p21-activated kinase-1 via phosphatidylinositol-3 kinase.
    Adam L; Vadlamudi R; Kondapaka SB; Chernoff J; Mendelsohn J; Kumar R
    J Biol Chem; 1998 Oct; 273(43):28238-46. PubMed ID: 9774445
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.